{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:51:44Z","timestamp":1790617904307,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["2014\/0020"],"award-info":[{"award-number":["2014\/0020"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00467-017-3876-0","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T16:26:43Z","timestamp":1516897603000},"page":"2057-2071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS)"],"prefix":"10.1007","volume":"33","author":[{"given":"Ramon Alfonso","family":"Exeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina Jimena","family":"Fernandez-Brando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Patricia","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Alejandra","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Mariana","family":"Exeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Victoria","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Sandra","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"3876_CR1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.163.6.1391","volume":"163","author":"M Jacewicz","year":"1986","unstructured":"Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT (1986) Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163:1391\u20131404","journal-title":"J Exp Med"},{"key":"3876_CR2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/IAI.58.3.611-618.1990","volume":"58","author":"JE Samuel","year":"1990","unstructured":"Samuel JE, Perera LP, Ward S, O\u2019Brien AD, Ginsburg V, Krivan HC (1990) Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun 58:611\u2013618","journal-title":"Infect Immun"},{"key":"3876_CR3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1160\/TH08-05-0317","volume":"101","author":"J Muthing","year":"2009","unstructured":"Muthing J, Schweppe CH, Karch H, Friedrich AW (2009) Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost 101:252\u2013264","journal-title":"Thromb Haemost"},{"key":"3876_CR4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.2009.7","volume":"75","author":"F Khan","year":"2009","unstructured":"Khan F, Proulx F, Lingwood CA (2009) Detergent-resistant globotriaosyl ceramide may define verotoxin\/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int 75:1209\u20131216","journal-title":"Kidney Int"},{"key":"3876_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/fmb.10.4","volume":"5","author":"VL Tesh","year":"2010","unstructured":"Tesh VL (2010) Induction of apoptosis by Shiga toxins. Future Microbiol 5:431\u2013453","journal-title":"Future Microbiol"},{"key":"3876_CR6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nrneph.2012.196","volume":"8","author":"H Trachtman","year":"2012","unstructured":"Trachtman H, Austin C, Lewinski M, Stahl RA (2012) Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 8:658\u2013669","journal-title":"Nat Rev Nephrol"},{"key":"3876_CR7","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1128\/IAI.67.11.5985-5993.1999","volume":"67","author":"CM Thorpe","year":"1999","unstructured":"Thorpe CM, Hurley BP, Lincicome LL, Jacewicz MS, Keusch GT, Acheson DW (1999) Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect Immun 67:5985\u20135993","journal-title":"Infect Immun"},{"key":"3876_CR8","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1128\/IAI.68.9.5183-5189.2000","volume":"68","author":"GH Foster","year":"2000","unstructured":"Foster GH, Armstrong CS, Sakiri R, Tesh VL (2000) Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases. Infect Immun 68:5183\u20135189","journal-title":"Infect Immun"},{"key":"3876_CR9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI57313","volume":"122","author":"TN Petruzziello-Pellegrini","year":"2012","unstructured":"Petruzziello-Pellegrini TN, Yuen DA, Page AV, Patel S, Soltyk AM, Matouk CC, Wong DK, Turgeon PJ, Fish JE, Ho JJ, Steer BM, Khajoee V, Tigdi J, Lee WL, Motto DG, Advani A, Gilbert RE, Karumanchi SA, Robinson LA, Tarr PI, Liles WC, Brunton JL, Marsden PA (2012) The CXCR4\/CXCR7\/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 122:759\u2013776","journal-title":"J Clin Invest"},{"key":"3876_CR10","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1182\/blood-2005-05-2111","volume":"106","author":"LH Nolasco","year":"2005","unstructured":"Nolasco LH, Turner NA, Bernardo A, Tao Z, Cleary TG, Dong JF, Moake JL (2005) Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood 106:4199\u20134209","journal-title":"Blood"},{"key":"3876_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1172\/JCI522","volume":"101","author":"MM Bitzan","year":"1998","unstructured":"Bitzan MM, Wang Y, Lin J, Marsden PA (1998) Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J Clin Invest 101:372\u2013382","journal-title":"J Clin Invest"},{"key":"3876_CR12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood.V85.7.1696.bloodjournal8571696","volume":"85","author":"M Morigi","year":"1995","unstructured":"Morigi M, Zoja C, Figliuzzi M, Foppolo M, Micheletti G, Bontempelli M, Saronni M, Remuzzi G, Remuzzi A (1995) Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood 85:1696\u20131703","journal-title":"Blood"},{"key":"3876_CR13","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood.V98.6.1828","volume":"98","author":"M Morigi","year":"2001","unstructured":"Morigi M, Galbusera M, Binda E, Imberti B, Gastoldi S, Remuzzi A, Zoja C, Remuzzi G (2001) Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 98:1828\u20131835","journal-title":"Blood"},{"key":"3876_CR14","doi-asserted-by":"crossref","first-page":"15484","DOI":"10.1016\/S0021-9258(18)82282-7","volume":"268","author":"TG Obrig","year":"1993","unstructured":"Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO (1993) Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268:15484\u201315488","journal-title":"J Biol Chem"},{"key":"3876_CR15","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1128\/IAI.61.9.3886-3891.1993","volume":"61","author":"SA Kaye","year":"1993","unstructured":"Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG (1993) Shiga toxin-associated hemolytic uremic syndrome:interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun 61:3886\u20133891","journal-title":"Infect Immun"},{"key":"3876_CR16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2002.00503.x","volume":"62","author":"C Zoja","year":"2002","unstructured":"Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, te Loo M, Monnens L, Remuzzi G, Morigi M (2002) Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 62:846\u2013856","journal-title":"Kidney Int"},{"key":"3876_CR17","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/toxins2122769","volume":"2","author":"TG Obrig","year":"2010","unstructured":"Obrig TG (2010) Escherichia coli Shiga toxin mechanisms of action in renal disease. Toxins (Basel) 2:2769\u20132794","journal-title":"Toxins (Basel)"},{"key":"3876_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-4274(98)00383-X","volume":"105","author":"JM Williams","year":"1999","unstructured":"Williams JM, Boyd B, Nutikka A, Lingwood CA, Barnett Foster DE, Milford DV, Taylor CM (1999) A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol Lett 105:47\u201357","journal-title":"Toxicol Lett"},{"key":"3876_CR19","first-page":"105","volume":"357","author":"TG Obrig","year":"2012","unstructured":"Obrig TG, Karpman D (2012) Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol 357:105\u2013136","journal-title":"Curr Top Microbiol Immunol"},{"key":"3876_CR20","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2353\/ajpath.2006.051331","volume":"169","author":"M Morigi","year":"2006","unstructured":"Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, Moioli D, Remuzzi G, Zoja C (2006) Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169:1965\u20131975","journal-title":"Am J Pathol"},{"key":"3876_CR21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1159\/000345142","volume":"36","author":"S Ohara","year":"2012","unstructured":"Ohara S, Kawasaki Y, Abe Y, Watanabe M, Ono A, Suyama K, Hashimoto K, Honda T, Suzuki J, Hosoya M (2012) Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome. Am J Nephrol 36:516\u2013523","journal-title":"Am J Nephrol"},{"key":"3876_CR22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/IAI.68.3.1207-1214.2000","volume":"68","author":"E Kita","year":"2000","unstructured":"Kita E, Yunou Y, Kurioka T, Harada H, Yoshikawa S, Mikasa K, Higashi N (2000) Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 68:1207\u20131214","journal-title":"Infect Immun"},{"key":"3876_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000445770","volume":"8","author":"MV Ramos","year":"2016","unstructured":"Ramos MV, Mejias MP, Sabbione F, Fernandez-Brando RJ, Santiago AP, Amaral MM, Exeni R, Trevani AS, Palermo MS (2016) Induction of neutrophil extracellular traps in Shiga toxin-associated hemolytic uremic syndrome. J Innate Immun 8:400\u2013411","journal-title":"J Innate Immun"},{"key":"3876_CR24","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1300122","volume":"191","author":"M Brigotti","year":"2013","unstructured":"Brigotti M, Carnicelli D, Arfilli V, Tamassia N, Borsetti F, Fabbri E, Tazzari PL, Ricci F, Pagliaro P, Spisni E, Cassatella MA (2013) Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. J Immunol 191:4748\u20134758","journal-title":"J Immunol"},{"key":"3876_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1432-1033.1985.tb08910.x","volume":"149","author":"B Kniep","year":"1985","unstructured":"Kniep B, Monner DA, Schwulera U, Muhlradt PF (1985) Glycosphingolipids of the globo-series are associated with the monocytic lineage of human myeloid cells. Eur J Biochem 149:187\u2013191","journal-title":"Eur J Biochem"},{"key":"3876_CR26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V88.1.174.174","volume":"88","author":"PA Setten van","year":"1996","unstructured":"van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, van Hinsbergh VW (1996) Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174\u2013183","journal-title":"Blood"},{"key":"3876_CR27","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.62.11.5085-5094.1994","volume":"62","author":"VL Tesh","year":"1994","unstructured":"Tesh VL, Ramegowda B, Samuel JE (1994) Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 62:5085\u20135094","journal-title":"Infect Immun"},{"key":"3876_CR28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/IAI.01700-06","volume":"75","author":"SY Lee","year":"2007","unstructured":"Lee SY, Cherla RP, Tesh VL (2007) Simultaneous induction of apoptotic and survival signaling pathways in macrophage-like THP-1 cells by Shiga toxin 1. Infect Immun 75:1291\u20131302","journal-title":"Infect Immun"},{"key":"3876_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2008.03698.x","volume":"153","author":"RJ Brando","year":"2008","unstructured":"Brando RJ, Miliwebsky E, Bentancor L, Deza N, Baschkier A, Ramos MV, Fernandez GC, Meiss R, Rivas M, Palermo MS (2008) Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains. Clin Exp Immunol 153:297\u2013306","journal-title":"Clin Exp Immunol"},{"key":"3876_CR30","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1128\/IAI.02191-14","volume":"82","author":"G Cabrera","year":"2014","unstructured":"Cabrera G, Fernandez-Brando RJ, Abrey-Recalde MJ, Baschkier A, Pinto A, Goldstein J, Zotta E, Meiss R, Rivas M, Palermo MS (2014) Retinoid levels influence enterohemorrhagic Escherichia coli infection and Shiga toxin 2 susceptibility in mice. Infect Immun 82:3948\u20133957","journal-title":"Infect Immun"},{"key":"3876_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2249.2000.01103.x","volume":"119","author":"M Palermo","year":"2000","unstructured":"Palermo M, Alves-Rosa F, Rubel C, Fernandez GC, Fernandez-Alonso G, Alberto F, Rivas M, Isturiz M (2000) Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119:77\u201383","journal-title":"Clin Exp Immunol"},{"key":"3876_CR32","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ajpath.2012.12.026","volume":"182","author":"DJ Stearns-Kurosawa","year":"2013","unstructured":"Stearns-Kurosawa DJ, SY O, Cherla RP, Lee MS, Tesh VL, Papin J, Henderson J, Kurosawa S (2013) Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli Shiga toxins in non-human primate models of hemolytic uremic syndrome. Am J Pathol 182:1227\u20131238","journal-title":"Am J Pathol"},{"key":"3876_CR33","doi-asserted-by":"crossref","first-page":"258185","DOI":"10.1155\/2011\/258185","volume":"2011","author":"KL Mohawk","year":"2011","unstructured":"Mohawk KL, O\u2019Brien AD (2011) Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection. J Biomed Biotechnol 2011:258185","journal-title":"J Biomed Biotechnol"},{"key":"3876_CR34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/591911","volume":"198","author":"F Obata","year":"2008","unstructured":"Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, Gross LK, Nelson MT, Sato S, Obrig TG (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 198:1398\u20131406","journal-title":"J Infect Dis"},{"key":"3876_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-2094-5-11","volume":"5","author":"K Takahashi","year":"2008","unstructured":"Takahashi K, Funata N, Ikuta F, Sato S (2008) Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 5:11","journal-title":"J Neuroinflammation"},{"key":"3876_CR36","doi-asserted-by":"crossref","first-page":"e55812","DOI":"10.1371\/journal.pone.0055812","volume":"8","author":"C Tironi-Farinati","year":"2013","unstructured":"Tironi-Farinati C, Geoghegan PA, Cangelosi A, Pinto A, Loidl CF, Goldstein J (2013) A translational murine model of sub-lethal intoxication with Shiga toxin 2 reveals novel ultrastructural findings in the brain striatum. PLoS One 8:e55812","journal-title":"PLoS One"},{"key":"3876_CR37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03155.x","volume":"146","author":"GC Fernandez","year":"2006","unstructured":"Fernandez GC, Lopez MF, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Dran GI, Meiss R, Isturiz MA, Palermo MS (2006) Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol 146:76\u201384","journal-title":"Clin Exp Immunol"},{"key":"3876_CR38","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/iub.1206","volume":"65","author":"C Ibarra","year":"2013","unstructured":"Ibarra C, Amaral MM, Palermo MS (2013) Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2. IUBMB Life 65:827\u2013835","journal-title":"IUBMB Life"},{"key":"3876_CR39","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1462-5822.2005.00673.x","volume":"8","author":"Y Miyamoto","year":"2006","unstructured":"Miyamoto Y, Iimura M, Kaper JB, Torres AG, Kagnoff MF (2006) Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol 8:869\u2013879","journal-title":"Cell Microbiol"},{"key":"3876_CR40","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2353\/ajpath.2008.071218","volume":"173","author":"C Calderon Toledo","year":"2008","unstructured":"Calderon Toledo C, Rogers TJ, Svensson M, Tati R, Fischer H, Svanborg C, Karpman D (2008) Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am J Pathol 173:1428\u20131439","journal-title":"Am J Pathol"},{"key":"3876_CR41","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1462-5822.2007.01071.x","volume":"10","author":"DL Gibson","year":"2008","unstructured":"Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C, Vallance BA (2008) MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol 10:618\u2013631","journal-title":"Cell Microbiol"},{"key":"3876_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229\u2013241","journal-title":"Cell"},{"key":"3876_CR43","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.181.2.1438","volume":"181","author":"S Kramer","year":"2008","unstructured":"Kramer S, Sellge G, Lorentz A, Krueger D, Schemann M, Feilhauer K, Gunzer F, Bischoff SC (2008) Selective activation of human intestinal mast cells by Escherichia coli hemolysin. J Immunol 181:1438\u20131445","journal-title":"J Immunol"},{"key":"3876_CR44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/gut.46.6.806","volume":"46","author":"CJ Bell","year":"2000","unstructured":"Bell CJ, Elliott EJ, Wallace JL, Redmond DM, Payne J, Li Z, O\u2019Loughlin EV (2000) Do eicosanoids cause colonic dysfunction in experimental E. coli O157:H7 (EHEC) infection? Gut 46:806\u2013812","journal-title":"Gut"},{"key":"3876_CR45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ijmm.2015.09.006","volume":"305","author":"G Cabrera","year":"2015","unstructured":"Cabrera G, Fernandez-Brando RJ, Mejias MP, Ramos MV, Abrey-Recalde MJ, Vanzulli S, Vermeulen M, Palermo MS (2015) Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection. Int J Med Microbiol 305:910\u2013917","journal-title":"Int J Med Microbiol"},{"key":"3876_CR46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/clim.2000.4862","volume":"95","author":"GC Fernandez","year":"2000","unstructured":"Fernandez GC, Rubel C, Dran G, Gomez S, Isturiz MA, Palermo MS (2000) Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome. Clin Immunol 95:227\u2013234","journal-title":"Clin Immunol"},{"key":"3876_CR47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2249.2005.02659.x","volume":"139","author":"SA Gomez","year":"2005","unstructured":"Gomez SA, Fernandez GC, Camerano G, Dran G, Rosa FA, Barrionuevo P, Isturiz MA, Palermo MS (2005) Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome. Clin Exp Immunol 139:65\u201373","journal-title":"Clin Exp Immunol"},{"key":"3876_CR48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2249.2003.02057.x","volume":"131","author":"SA Gomez","year":"2003","unstructured":"Gomez SA, Fernandez GC, Vanzulli S, Dran G, Rubel C, Berki T, Isturiz MA, Palermo MS (2003) Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome. Clin Exp Immunol 131:217\u2013224","journal-title":"Clin Exp Immunol"},{"key":"3876_CR49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/cei.12124","volume":"173","author":"SA Gomez","year":"2013","unstructured":"Gomez SA, Abrey-Recalde MJ, Panek CA, Ferrarotti NF, Repetto MG, Mejias MP, Fernandez GC, Vanzulli S, Isturiz MA, Palermo MS (2013) The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome. Clin Exp Immunol 173:463\u2013472","journal-title":"Clin Exp Immunol"},{"key":"3876_CR50","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1476-5381.1989.tb12572.x","volume":"97","author":"D Salvemini","year":"1989","unstructured":"Salvemini D, de Nucci G, Sneddon JM, Vane JR (1989) Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol 97:1145\u20131150","journal-title":"Br J Pharmacol"},{"key":"3876_CR51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0002-9343(00)00612-4","volume":"109","author":"KA Nath","year":"2000","unstructured":"Nath KA, Norby SM (2000) Reactive oxygen species and acute renal failure. Am J Med 109:665\u2013678","journal-title":"Am J Med"},{"key":"3876_CR52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2249.1999.00925.x","volume":"116","author":"MS Palermo","year":"1999","unstructured":"Palermo MS, Alves Rosa MF, Van Rooijen N, Isturiz MA (1999) Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Clin Exp Immunol 116:462\u2013467","journal-title":"Clin Exp Immunol"},{"key":"3876_CR53","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ajpath.2011.11.011","volume":"180","author":"MV Ramos","year":"2012","unstructured":"Ramos MV, Auvynet C, Poupel L, Rodero M, Mejias MP, Panek CA, Vanzulli S, Combadiere C, Palermo M (2012) Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome. Am J Pathol 180:1040\u20131048","journal-title":"Am J Pathol"},{"key":"3876_CR54","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1128\/IAI.01663-06","volume":"75","author":"TR Keepers","year":"2007","unstructured":"Keepers TR, Gross LK, Obrig TG (2007) Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect Immun 75:1229\u20131236","journal-title":"Infect Immun"},{"key":"3876_CR55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2353\/ajpath.2007.060366","volume":"170","author":"JK Roche","year":"2007","unstructured":"Roche JK, Keepers TR, Gross LK, Seaner RM, Obrig TG (2007) CXCL1\/KC and CXCL2\/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am J Pathol 170:526\u2013537","journal-title":"Am J Pathol"},{"key":"3876_CR56","doi-asserted-by":"publisher","unstructured":"Obata F, Obrig T (2014) Role of Shiga\/Vero toxins in pathogenesis. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.EHEC-0005-2013","DOI":"10.1128\/microbiolspec.EHEC-0005-2013"},{"key":"3876_CR57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.micpath.2012.05.005","volume":"53","author":"MS Lucero","year":"2012","unstructured":"Lucero MS, Mirarchi F, Goldstein J, Silberstein C (2012) Intraperitoneal administration of Shiga toxin 2 induced neuronal alterations and reduced the expression levels of aquaporin 1 and aquaporin 4 in rat brain. Microb Pathog 53:87\u201394","journal-title":"Microb Pathog"},{"key":"3876_CR58","doi-asserted-by":"crossref","first-page":"e58959","DOI":"10.1371\/journal.pone.0058959","volume":"8","author":"MY Amran","year":"2013","unstructured":"Amran MY, Fujii J, Suzuki SO, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S (2013) Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice. PLoS One 8:e58959","journal-title":"PLoS One"},{"key":"3876_CR59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/IAI.66.1.197-202.1998","volume":"66","author":"E Isogai","year":"1998","unstructured":"Isogai E, Isogai H, Kimura K, Hayashi S, Kubota T, Fujii N, Takeshi K (1998) Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun 66:197\u2013202","journal-title":"Infect Immun"},{"key":"3876_CR60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2016.00114","volume":"6","author":"S Pradhan","year":"2016","unstructured":"Pradhan S, Pellino C, MacMaster K, Coyle D, Weiss AA (2016) Shiga toxin mediated neurologic changes in Murine model of disease. Front Cell Infect Microbiol 6:114","journal-title":"Front Cell Infect Microbiol"},{"key":"3876_CR61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/path.4388","volume":"234","author":"S Porubsky","year":"2014","unstructured":"Porubsky S, Federico G, Muthing J, Jennemann R, Gretz N, Buttner S, Obermuller N, Jung O, Hauser IA, Grone E, Geiger H, Grone HJ, Betz C (2014) Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure. J Pathol 234:120\u2013133","journal-title":"J Pathol"},{"key":"3876_CR62","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00006454-200007000-00012","volume":"19","author":"C Buteau","year":"2000","unstructured":"Buteau C, Proulx F, Chaibou M, Raymond D, Clermont MJ, Mariscalco MM, Lebel MH, Seidman E (2000) Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 19:642\u2013647","journal-title":"Pediatr Infect Dis J"},{"key":"3876_CR63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1203\/01.pdr.0000250037.47169.55","volume":"61","author":"GC Fernandez","year":"2007","unstructured":"Fernandez GC, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Lopez L, Ramirez F, Diaz M, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS (2007) The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome. Pediatr Res 61:123\u2013128","journal-title":"Pediatr Res"},{"key":"3876_CR64","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s004670050337","volume":"11","author":"CD Inward","year":"1997","unstructured":"Inward CD, Howie AJ, Fitzpatrick MM, Rafaat F, Milford DV, Taylor CM (1997) Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology. Pediatr Nephrol 11:556\u2013559","journal-title":"Pediatr Nephrol"},{"key":"3876_CR65","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1203\/00006450-199806000-00008","volume":"43","author":"PA Setten van","year":"1998","unstructured":"van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA (1998) Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res 43:759\u2013767","journal-title":"Pediatr Res"},{"key":"3876_CR66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1189\/jlb.0709475","volume":"88","author":"M Brigotti","year":"2010","unstructured":"Brigotti M, Tazzari PL, Ravanelli E, Carnicelli D, Barbieri S, Rocchi L, Arfilli V, Scavia G, Ricci F, Bontadini A, Alfieri RR, Petronini PG, Pecoraro C, Tozzi AE, Caprioli A (2010) Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. J Leukoc Biol 88:201\u2013210","journal-title":"J Leukoc Biol"},{"key":"3876_CR67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00467-011-2014-7","volume":"27","author":"PG Valles","year":"2012","unstructured":"Valles PG, Melechuck S, Gonzalez A, Manucha W, Bocanegra V, Valles R (2012) Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome. Pediatr Nephrol 27:407\u2013415","journal-title":"Pediatr Nephrol"},{"key":"3876_CR68","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00467-005-1906-9","volume":"20","author":"GC Fernandez","year":"2005","unstructured":"Fernandez GC, Gomez SA, Rubel CJ, Bentancor LV, Barrionuevo P, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS (2005) Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr Nephrol 20:1306\u20131314","journal-title":"Pediatr Nephrol"},{"key":"3876_CR69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00467-002-0832-3","volume":"17","author":"GC Fernandez","year":"2002","unstructured":"Fernandez GC, Rubel C, Barrionuevo P, Lopez L, Ramirez F, Diaz M, Isturiz MA, Palermo MS (2002) Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome. Pediatr Nephrol 17:337\u2013344","journal-title":"Pediatr Nephrol"},{"key":"3876_CR70","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532\u20131535","journal-title":"Science"},{"issue":"36","key":"3876_CR71","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"T. A. Fuchs","year":"2010","unstructured":"Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Jr., Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107:15880-15885","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"3876_CR72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15:623\u2013625","journal-title":"Nat Med"},{"key":"3876_CR73","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","volume":"120","author":"TA Fuchs","year":"2012","unstructured":"Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lammle B (2012) Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 120:1157\u20131164","journal-title":"Blood"},{"key":"3876_CR74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000450609","volume":"9","author":"J Leffler","year":"2017","unstructured":"Leffler J, Prohaszka Z, Mikes B, Sinkovits G, Ciacma K, Farkas P, Reti M, Kelen K, Reusz GS, Szabo AJ, Martin M, Blom AM (2017) Decreased neutrophil extracellular trap degradation in Shiga toxin-associated haemolytic uraemic syndrome. J Innate Immun 9:12\u201321","journal-title":"J Innate Immun"},{"key":"3876_CR75","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML Bruhl von","year":"2012","unstructured":"von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Kollnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, Eckart A, Haidari S, Rudelius M, Schulz C, Echtler K, Brinkmann V, Schwaiger M, Preissner KT, Wagner DD, Mackman N, Engelmann B, Massberg S (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819\u2013835","journal-title":"J Exp Med"},{"key":"3876_CR76","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cei.12654","volume":"181","author":"H Wang","year":"2015","unstructured":"Wang H, Wang C, Zhao MH, Chen M (2015) Neutrophil extracellular traps can activate alternative complement pathways. Clin Exp Immunol 181:518\u2013527","journal-title":"Clin Exp Immunol"},{"key":"3876_CR77","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","volume":"188","author":"J Leffler","year":"2012","unstructured":"Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, Bengtsson AA, Blom AM (2012) Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 188:3522\u20133531","journal-title":"J Immunol"},{"key":"3876_CR78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","volume":"187","author":"M Morigi","year":"2011","unstructured":"Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C (2011) Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187:172\u2013180","journal-title":"J Immunol"},{"key":"3876_CR79","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","volume":"117","author":"AL Stahl","year":"2011","unstructured":"Stahl AL, Sartz L, Karpman D (2011) Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117:5503\u20135513","journal-title":"Blood"},{"key":"3876_CR80","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1681\/ASN.2013050450","volume":"25","author":"M Locatelli","year":"2014","unstructured":"Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M (2014) Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J Am Soc Nephrol 25:1786\u20131798","journal-title":"J Am Soc Nephrol"},{"key":"3876_CR81","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1161\/ATVBAHA.107.159178","volume":"28","author":"JE Freedman","year":"2008","unstructured":"Freedman JE (2008) Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 28:s11\u2013s16","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3876_CR82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.autrev.2009.02.020","volume":"8","author":"C Perricone","year":"2009","unstructured":"Perricone C, De Carolis C, Perricone R (2009) Glutathione: a key player in autoimmunity. Autoimmun Rev 8:697\u2013701","journal-title":"Autoimmun Rev"},{"key":"3876_CR83","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/ndt\/gfq511","volume":"26","author":"V Ferraris","year":"2011","unstructured":"Ferraris V, Acquier A, Ferraris JR, Vallejo G, Paz C, Mendez CF (2011) Oxidative stress status during the acute phase of haemolytic uraemic syndrome. Nephrol Dial Transplant 26:858\u2013864","journal-title":"Nephrol Dial Transplant"},{"key":"3876_CR84","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tiv.2010.11.006","volume":"25","author":"V Aiassa","year":"2011","unstructured":"Aiassa V, Baronetti JL, Paez PL, Barnes AI, Albrecht C, Pellarin G, Eraso AJ, Albesa I (2011) Increased advanced oxidation of protein products and enhanced total antioxidant capacity in plasma by action of toxins of Escherichia coli STEC. Toxicol in Vitro 25:426\u2013431","journal-title":"Toxicol in Vitro"},{"key":"3876_CR85","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/08860229309054968","volume":"15","author":"S Li Volti","year":"1993","unstructured":"Li Volti S, Di Giacomo C, Garozzo R, Campisi A, Mollica F, Vanella A (1993) Impaired antioxidant defense mechanisms in two children with hemolytic-uremic syndrome. Ren Fail 15:523\u2013528","journal-title":"Ren Fail"},{"key":"3876_CR86","first-page":"137","volume":"47","author":"G Facorro","year":"1997","unstructured":"Facorro G, Aguirre F, Florentin L, Diaz M, De Paoli T, Ihlo JE, Hager AA, Sanchez Avalos JC, Farach HA, Poole CP Jr (1997) Oxidative stress and membrane fluidity in erythrocytes from patients with hemolytic uremic syndrome. Acta Physiol Pharmacol Ther Latinoam 47:137\u2013146","journal-title":"Acta Physiol Pharmacol Ther Latinoam"},{"key":"3876_CR87","first-page":"153","volume":"37","author":"NK Dubey","year":"2000","unstructured":"Dubey NK, Yadav P, Dutta AK, Kumar V, Ray GN, Batra S (2000) Free oxygen radicals in acute renal failure. Indian Pediatr 37:153\u2013158","journal-title":"Indian Pediatr"},{"key":"3876_CR88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/adc.59.5.401","volume":"59","author":"HR Powell","year":"1984","unstructured":"Powell HR, McCredie DA, Taylor CM, Burke JR, Walker RG (1984) Vitamin E treatment of haemolytic uraemic syndrome. Arch Dis Child 59:401\u2013404","journal-title":"Arch Dis Child"},{"key":"3876_CR89","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1189\/jlb.0505251","volume":"78","author":"GC Fernandez","year":"2005","unstructured":"Fernandez GC, Ramos MV, Gomez SA, Dran GI, Exeni R, Alduncin M, Grimoldi I, Vallejo G, Elias-Costa C, Isturiz MA, Palermo MS (2005) Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. J Leukoc Biol 78:853\u2013861","journal-title":"J Leukoc Biol"},{"key":"3876_CR90","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10875-011-9646-z","volume":"32","author":"GC Fernandez","year":"2012","unstructured":"Fernandez GC, Ramos MV, Landoni VI, Bentancor LV, Fernandez-Brando RJ, Exeni R, Laso Mdel C, Exeni A, Grimoldi I, Isturiz MA, Palermo MS (2012) Cytokine production is altered in monocytes from children with hemolytic uremic syndrome. J Clin Immunol 32:622\u2013631","journal-title":"J Clin Immunol"},{"key":"3876_CR91","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/CS20150016","volume":"129","author":"MV Ramos","year":"2015","unstructured":"Ramos MV, Ruggieri M, Panek AC, Mejias MP, Fernandez-Brando RJ, Abrey-Recalde MJ, Exeni A, Barilari C, Exeni R, Palermo MS (2015) Association of haemolytic uraemic syndrome with dysregulation of chemokine receptor expression in circulating monocytes. Clin Sci (Lond) 129:235\u2013244","journal-title":"Clin Sci (Lond)"},{"key":"3876_CR92","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood-2006-06-026997","volume":"109","author":"MV Ramos","year":"2007","unstructured":"Ramos MV, Fernandez GC, Patey N, Schierloh P, Exeni R, Grimoldi I, Vallejo G, Elias-Costa C, Del Carmen Sasiain M, Trachtman H, Combadiere C, Proulx F, Palermo MS (2007) Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome. Blood 109:2438\u20132445","journal-title":"Blood"},{"key":"3876_CR93","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1203\/00006450-200212000-00019","volume":"52","author":"F Proulx","year":"2002","unstructured":"Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG (2002) Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Pediatr Res 52:928\u2013934","journal-title":"Pediatr Res"},{"key":"3876_CR94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0272-6386(00)70297-6","volume":"35","author":"F Proulx","year":"2000","unstructured":"Proulx F, Litalien C, Turgeon JP, Mariscalco MM, Seidman E (2000) Circulating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome. Am J Kidney Dis 35:29\u201334","journal-title":"Am J Kidney Dis"},{"key":"3876_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2013.12.005","volume":"66","author":"M Shimizu","year":"2014","unstructured":"Shimizu M, Kuroda M, Inoue N, Konishi M, Igarashi N, Taneichi H, Kanegane H, Ito M, Saito S, Yachie A (2014) Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. Cytokine 66:1\u20136","journal-title":"Cytokine"},{"key":"3876_CR96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2008.02.012","volume":"196","author":"M Shiraishi","year":"2008","unstructured":"Shiraishi M, Ichiyama T, Matsushige T, Iwaki T, Iyoda K, Fukuda K, Makata H, Matsubara T, Furukawa S (2008) Soluble tumor necrosis factor. Receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy. J Neuroimmunol 196:147\u2013152","journal-title":"J Neuroimmunol"},{"key":"3876_CR97","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1006\/cyto.1997.0329","volume":"10","author":"A Murata","year":"1998","unstructured":"Murata A, Shimazu T, Yamamoto T, Taenaka N, Nagayama K, Honda T, Sugimoto H, Monden M, Matsuura N, Okada S (1998) Profiles of circulating inflammatory- and anti-inflammatory cytokines in patients with hemolytic uremic syndrome due to E. coli O157 infection. Cytokine 10:544\u2013548","journal-title":"Cytokine"},{"key":"3876_CR98","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/infdis\/jit268","volume":"208","author":"AV Page","year":"2013","unstructured":"Page AV, Tarr PI, Watkins SL, Rajwans N, Petruzziello-Pellegrini TN, Marsden PA, Kain KC, Liles WC (2013) Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome. J Infect Dis 208:929\u2013933","journal-title":"J Infect Dis"},{"key":"3876_CR99","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1542\/peds.88.5.1063","volume":"88","author":"RL Siegler","year":"1991","unstructured":"Siegler RL, Edwin SS, Christofferson RD, Mitchell MD (1991) Endothelin in the urine of children with the hemolytic uremic syndrome. Pediatrics 88:1063\u20131066","journal-title":"Pediatrics"},{"key":"3876_CR100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000045607","volume":"84","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto T, Nagayama K, Satomura K, Honda T, Okada S (2000) Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157. Nephron 84:326\u2013332","journal-title":"Nephron"},{"key":"3876_CR101","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1203\/01.pdr.0000203100.45658.d5","volume":"59","author":"H Decaluwe","year":"2006","unstructured":"Decaluwe H, Harrison LM, Mariscalco MM, Gendrel D, Bohuon C, Tesh VL, Proulx F (2006) Procalcitonin in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Pediatr Res 59:579\u2013583","journal-title":"Pediatr Res"},{"key":"3876_CR102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","volume":"62","author":"WL Robson","year":"1992","unstructured":"Robson WL, Leung AK, Fick GH, McKenna AI (1992) Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 62:296\u2013299","journal-title":"Nephron"},{"key":"3876_CR103","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","volume":"4","author":"JM Thurman","year":"2009","unstructured":"Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H, Holers VM, Lesser M, Kline M, Hoffman C, Christen E, Trachtman H (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1920\u20131924","journal-title":"Clin J Am Soc Nephrol"},{"key":"3876_CR104","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cei.12601","volume":"181","author":"JR Ferraris","year":"2015","unstructured":"Ferraris JR, Ferraris V, Acquier AB, Sorroche PB, Saez MS, Ginaca A, Mendez CF (2015) Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome. Clin Exp Immunol 181:118\u2013125","journal-title":"Clin Exp Immunol"},{"key":"3876_CR105","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.4049\/jimmunol.1402470","volume":"194","author":"I Arvidsson","year":"2015","unstructured":"Arvidsson I, Stahl AL, Hedstrom MM, Kristoffersson AC, Rylander C, Westman JS, Storry JR, Olsson ML, Karpman D (2015) Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome. J Immunol 194:2309\u20132318","journal-title":"J Immunol"},{"key":"3876_CR106","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfw078","volume":"31","author":"T Ahlenstiel-Grunow","year":"2016","unstructured":"Ahlenstiel-Grunow T, Hachmeister S, Bange FC, Wehling C, Kirschfink M, Bergmann C, Pape L (2016) Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli-associated paediatric haemolytic uraemic syndrome. Nephrol Dial Transplant 31:1114\u20131121","journal-title":"Nephrol Dial Transplant"},{"key":"3876_CR107","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-0034-1375295","volume":"40","author":"D Orth-Holler","year":"2014","unstructured":"Orth-Holler D, Wurzner R (2014) Role of complement in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Semin Thromb Hemost 40:503\u2013507","journal-title":"Semin Thromb Hemost"},{"key":"3876_CR108","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-Holler D, Wurzner R, Karch H (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 54:1413\u20131421","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"3876_CR109","first-page":"6","volume":"66","author":"RA Exeni","year":"2006","unstructured":"Exeni RA (2006) Hemolytic uremic syndrome. Clinical manifestations. Treatment. Medicina (B Aires) 66(Suppl 3):6\u201310","journal-title":"Medicina (B Aires)"},{"key":"3876_CR110","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/brain\/aws090","volume":"135","author":"T Magnus","year":"2012","unstructured":"Magnus T, Rother J, Simova O, Meier-Cillien M, Repenthin J, Moller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C (2012) The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135:1850\u20131859","journal-title":"Brain"},{"key":"3876_CR111","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","volume":"345","author":"J Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmuller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Munte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schocklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhoner P, Wiesner M, Zeissig S, Buning J, Schiffer M, Kuehbacher T (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 345:e4565","journal-title":"BMJ"},{"key":"3876_CR112","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","volume":"29","author":"Y Delmas","year":"2014","unstructured":"Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Helou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C (2014) Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29:565\u2013572","journal-title":"Nephrol Dial Transplant"},{"key":"3876_CR113","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0009922814534520","volume":"54","author":"A Saini","year":"2015","unstructured":"Saini A, Emke AR, Silva MC, Perlman SJ (2015) Response to Eculizumab in Escherichia coli O157:H7-induced hemolytic uremic syndrome with severe neurological manifestations. Clin Pediatr (Phila) 54:387\u2013389","journal-title":"Clin Pediatr (Phila)"},{"key":"3876_CR114","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1097\/MD.0000000000001000","volume":"94","author":"L Pape","year":"2015","unstructured":"Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T (2015) Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 94:e1000","journal-title":"Medicine (Baltimore)"},{"key":"3876_CR115","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","volume":"364","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F (2011) Eculizumab in severe Shiga-Toxin-Associated HUS. N Engl J Med 364:2561\u20132563","journal-title":"N Engl J Med"},{"key":"3876_CR116","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1212\/WNL.0000000000000120","volume":"82","author":"J Takanashi","year":"2014","unstructured":"Takanashi J, Taneichi H, Misaki T, Yahata Y, Okumura A, Ishida Y, Miyawaki T, Okabe N, Sata T, Mizuguchi M (2014) Clinical and radiologic features of encephalopathy during 2011 E. coli O111 outbreak in Japan. Neurology 82:564\u2013572","journal-title":"Neurology"},{"key":"3876_CR117","first-page":"395","volume":"65","author":"PG Valles","year":"2005","unstructured":"Valles PG, Pesle S, Piovano L, Davila E, Peralta M, Principi I, Lo Giudice P (2005) Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina (B Aires) 65:395\u2013401","journal-title":"Medicina (B Aires)"},{"key":"3876_CR118","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10157-014-0995-9","volume":"18","author":"T Igarashi","year":"2014","unstructured":"Igarashi T, Ito S, Sako M, Saitoh A, Hataya H, Mizuguchi M, Morishima T, Ohnishi K, Kawamura N, Kitayama H, Ashida A, Kaname S, Taneichi H, Tang J, Ohnishi M (2014) Guidelines for the management and investigation of hemolytic uremic syndrome. Clin Exp Nephrol 18:525\u2013557","journal-title":"Clin Exp Nephrol"},{"key":"3876_CR119","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bpa.12166","volume":"25","author":"C Hagel","year":"2015","unstructured":"Hagel C, Krasemann S, Loffler J, Puschel K, Magnus T, Glatzel M (2015) Upregulation of Shiga toxin receptor CD77\/Gb3 and interleukin-1beta expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms. Brain Pathol 25:146\u2013156","journal-title":"Brain Pathol"},{"key":"3876_CR120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuint.2015.04.003","volume":"85-86","author":"Mondo Kuroda","year":"2015","unstructured":"Kuroda M, Shimizu M, Inoue N, Ikeno I, Nakagawa H, Yokoi A, Niida Y, Konishi M, Kaneda H, Igarashi N, Yamahana J, Taneichi H, Kanegane H, Ito M, Saito S, Furuichi K, Wada T, Nakagawa M, Yokoyama H, Yachie A (2015) Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome. Neurochem Int 85\u201386:24\u201330","journal-title":"Neurochemistry International"},{"key":"3876_CR121","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1100\/tsw.2007.172","volume":"7","author":"RA Exeni","year":"2007","unstructured":"Exeni RA, Fernandez GC, Palermo MS (2007) Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome. Sci World J 7:1155\u20131164","journal-title":"Sci World J"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3876-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T15:07:56Z","timestamp":1719760076000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3876-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":121,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3876"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3876-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"19 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}